A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study.

Ramón VirasoroJessica M DeLongRafael E EstrellaMerycarla PichardoRamón Rodriguez LayGustavo EspinoSean P Elliott

Published in: Research and reports in urology (2022)

Symptomatic improvement after treatment with the Optilume DCB was maintained through 3 years in a population highly susceptible to recurrent urethral stricture disease. This minimally invasive therapy is safe with no negative impact on sexual function.

Keyphrases

minimally invasive
endoscopic submucosal dissection
stem cells
bone marrow
cell therapy
smoking cessation